Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
about
Hormonal Modulation of Breast Cancer Gene Expression: Implications for Intrinsic Subtyping in Premenopausal WomenUse of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineSelecting postoperative adjuvant systemic therapy for early stage breast cancer: A critical assessment of commercially available gene expression assays.Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease.Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-studyBiological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry.From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies.Gene expression-based prognostic and predictive tools in breast cancer.Indications for prognostic gene expression profiling in early breast cancer.Biomarker assessment and molecular testing for prognostication in breast cancer.Clinical utility of gene-expression signatures in early stage breast cancer.Synthesis of Saccharumoside-B analogue with potential of antiproliferative and pro-apoptotic activities.Analytical validation of a 12-gene molecular test for the prediction of distant recurrence in breast cancer.Developing a new generation of breast cancer clinical gene expression testsAssessing the Clinical Benefit of Systemic Adjuvant Therapies for Early Breast Cancer.Cost Effectiveness of Gene Expression Profile Testing in Community Practice.Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology.[Molecular pathology for breast cancer: Importance of the gene expression profile].Prognostic & predictive factors for planning adjuvant chemotherapy of early-stage breast cancer.An Update on Breast Cancer Multigene Prognostic Tests-Emergent Clinical BiomarkersIntrinsic cancer subtypes-next steps into personalized medicine
P2860
Q28077637-D6CB9683-847F-4E10-86B1-BA9250B920FEQ28079118-91230462-5D85-41D3-AFA2-E4F2EA31F164Q33834198-A4B02770-A4BF-447A-BFE7-3D829924A5C7Q33897072-60BA6BBA-C3AA-46B2-A76B-E379848C85D6Q36678505-B6DE125B-1D8F-438B-9CF6-FCE985BF1104Q36994974-18C58F0B-7259-44DD-A918-C11B99ACCA93Q37214217-A5BF9B17-49F5-4CEB-B419-1D779341C774Q37590339-6733C59F-C3C9-4A42-857E-ABC4CAD78605Q38421414-2458542C-A696-49C4-93D4-D9D5191F7655Q38451798-2AB725B0-97E1-41C7-9BFE-143D6395C712Q38696790-901608E8-2C01-42B9-A3E1-368B92BEA1C5Q38754717-E54899A6-4E6D-49A5-BA1A-912C9CDDEEADQ41436661-BA2412BE-F149-4620-8945-228BA53C2218Q41608998-AA0555B1-13EB-465C-90BA-09361CB22565Q42737349-642011D7-391D-4069-8CE4-3A95680408E5Q47138534-0EC39BED-E47F-475C-B642-C22C3BBEDC32Q47198620-4A5D6464-4371-4983-8157-D37DABD79736Q48353102-38E87E92-642E-408C-AA79-359600D3D419Q52868166-53C7AD8D-0491-4FF5-A7CE-8A73B3963331Q54495437-AE05C2D3-98D2-40AB-80FF-183B8F3A03C1Q57106403-66E4042E-5794-4EF5-84A5-62E55123E9C1Q58053534-D3759FCA-A18C-4229-8ED5-12FCFF140CB2
P2860
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@ast
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@en
type
label
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@ast
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@en
prefLabel
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@ast
Clinical validation of the End ...... ts from the GEICAM 9906 trial.
@en
P2093
P2860
P356
P1476
Clinical validation of the End ...... lts from the GEICAM 9906 trial
@en
P2093
Alvaro Rodriguez-Lescure
Amparo Ruiz
Blanca Munarriz
Carmen Crespo
Cesar A Rodriguez
Christoph Petry
Emilio Alba
Eva Carrasco
Jan C Brase
Karin Fisch
P2860
P2888
P356
10.1186/BCR3642
P577
2014-04-12T00:00:00Z
P5875
P6179
1038037714